|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Revenues, net | |||||
| Cost of revenues | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Impairment expense | |||||
| Operating income | |||||
| Interest expense, net | |||||
| Other expense, net | |||||
| Income before income taxes | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Income attributable to redeemable noncontrolling interest | |||||
| Net income attributable to CSW | |||||
| Basic earnings per common share: (in USD per share) | |||||
| Diluted earnings per common share (in USD per share) | |||||
| Net income per share attributable to CSW | |||||
| Basic (in USD per share) | |||||
| Diluted (in USD per share) | |||||
| Weighted average number of shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...